CrossrefInfokarte
Synthetic Inhibitors of CDK4/6 Activities and Tumor Suppression: A Preface to the Special Issue
Onco · 2021
DOI: 10.3390/onco1010001 ↗Abstract
The status of RB1 in cancer may help us determine the optimal therapeutic approach to patients [...]
EUVIMED